| 1. | rzoro41 | |
| 2. | metalbarha | |
| 3. | amay464 | |
| 4. | wantgoodone |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | wantgoodone 09/13/2018 FDA has granted Fast Track designation for the company’s anti-CTGF antibody, pamrevlumab |
| 2. | metalbarha 06/04/2018 Presents clinical results of Pamrevlumab; |
| 3. | rzoro41 02/27/2018 Still!! |
| 4. | rzoro41 03/01/2018 Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer |
| 5. | amay464 06/03/2018 FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
FibroGen, Inc
- FGEN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.